CHEMOTHERAPY: Maintenance therapy in breast cancer—many questions remain

    loading  Checking for direct PDF access through Ovid

Abstract

A recent clinical trial showed that a significant progression-free and overall survival benefit was associated with maintenance chemotherapy in patients with HER2-negative metastatic breast cancer who have disease control after six cycles of conventional chemotherapy. However, the choice of observation alone as the control arm limits the clinical application of these data.

Related Topics

    loading  Loading Related Articles